Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$2.69B+3.9%$2.59B+2.8%$2.52B+2.8%$2.45B+1.0%$2.43B-0.2%
$553M+1.8%$543M+1.7%$534M+1.3%$527M+1.0%$522M-0.9%
-$29M+3.3%-$30M-42.9%-$21M-16.7%
$237M+7.7%$220M+18.3%$186M-3.1%$192M-8.1%$209M-11.1%
-$242M-4.3%-$232M-627%$44M-90.0%$442M+16.0%$381M+10.1%
-$0.50-6.4%-$0.47-622%$0.09-90.0%$0.90+15.4%$0.78+11.4%
2B+0.3%2B0.0%2B0.0%2B+0.3%2B+0.2%
-$29M+3.3%-$30M-42.9%-$21M-16.7%
$244M+3.0%$237M+464%$42M+23.5%$34M-69.9%$113M-24.7%
$731M+8.1%$676M
$40M+1,100%-$4M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Elanco Animal Health Inc.'s revenue?
Elanco Animal Health Inc. (ELAN) generated $4.9B in revenue over the trailing twelve months, up 10.5% year over year.
Is Elanco Animal Health Inc. profitable?
Elanco Animal Health Inc. is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months, a -4.9% net margin.
What is Elanco Animal Health Inc.'s earnings per share?
Elanco Animal Health Inc.'s diluted EPS over the trailing twelve months is $-0.50.
Where does Elanco Animal Health Inc.'s income statement data come from?
Every line is extracted from Elanco Animal Health Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.